ClinicalTrials.Veeva

Menu

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

U

University Hospital Muenster

Status

Enrolling

Conditions

Endovascular Aortic Repair
Stent-Graft Endoleak
Aortic Aneurysm

Treatments

Device: Semibranch CMD branched aortic stentgraft

Study type

Observational

Funder types

Other

Identifiers

NCT06059053
Semibranch_Reg

Details and patient eligibility

About

The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.

Full description

The main question it aims to answer are:

  • Patency of the semibranch
  • Feasibility of the technique regarding cannulation and stentgrafting

The participants will treated with the custom made semibranch device and enrolled in the registry if they consent. No change in treatment will be made when enrolled.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Presence of pararenal or thoracoabdominal aortic pathology
  • Treatment planned a semibranch device branch from Artivion
  • Availability of the patients during the follow up period
  • Informing patients about the study and providing written informed consent

Exclusion criteria

  • Women of childbearing age
  • Patients under 18 years

Trial contacts and locations

1

Loading...

Central trial contact

Alexander Oberhuber, MD,PhD; vascular trial unit

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems